{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:27:25Z","timestamp":1777418845300,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.amepre.2005.08.042","type":"journal-article","created":{"date-parts":[[2006,1,18]],"date-time":"2006-01-18T20:23:45Z","timestamp":1137615825000},"page":"74-77","source":"Crossref","is-referenced-by-count":133,"title":["Aspirin Use Among U.S. Adults"],"prefix":"10.1016","volume":"30","author":[{"given":"Umed A.","family":"Ajani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Earl S.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt J.","family":"Greenland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne H.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali H.","family":"Mokdad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2005.08.042_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1079\/PHN2003587","article-title":"Diet, nutrition and the prevention of hypertension and cardiovascular diseases","volume":"7","author":"Srinath","year":"2004","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.amepre.2005.08.042_bib2","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1161\/01.CIR.0000075572.40158.77","article-title":"Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease","volume":"107","author":"Thompson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amepre.2005.08.042_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0733-8651(05)70260-5","article-title":"Cigarette smoking and coronary heart disease","volume":"14","author":"Rigotti","year":"1996","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.amepre.2005.08.042_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35)","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.amepre.2005.08.042_bib5","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","article-title":"Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs","volume":"356","author":"Neal","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.amepre.2005.08.042_bib6","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.amepre.2005.08.042_bib7","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/archinte.164.14.1490","article-title":"A practical and evidence-based approach to cardiovascular disease risk reduction","volume":"164","author":"Gluckman","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amepre.2005.08.042_bib8","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amepre.2005.08.042_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/01.CIR.80.4.749","article-title":"Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease","volume":"80","author":"Hennekens","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.amepre.2005.08.042_bib10","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1001\/archinte.163.17.2006","article-title":"An update on aspirin in the primary prevention of cardiovascular disease","volume":"163","author":"Eidelman","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amepre.2005.08.042_bib11","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1001\/archinte.162.19.2197","article-title":"Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events","volume":"162","author":"Weisman","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amepre.2005.08.042_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.amepre.2005.08.042_bib13","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1161\/01.CIR.96.8.2751","article-title":"Aspirin as a therapeutic agent in cardiovascular disease","volume":"96","author":"Hennekens","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amepre.2005.08.042_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.CIR.0000020190.45892.75","article-title":"AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 update. Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee","volume":"106","author":"Pearson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amepre.2005.08.042_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-136-2-200201150-00015","article-title":"Aspirin for the primary prevention of cardiovascular events","volume":"136","year":"2002","journal-title":"Ann Intern Med"},{"issue":"suppl 1","key":"10.1016\/j.amepre.2005.08.042_bib16","first-page":"S72","article-title":"Aspirin therapy in diabetes","volume":"27","author":"Colwell","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amepre.2005.08.042_bib17","series-title":"Healthy People 2010","year":"2000"},{"key":"10.1016\/j.amepre.2005.08.042_bib18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0002-8703(96)90173-8","article-title":"Patterns of aspirin use in middle-aged adults","volume":"131","author":"Shahar","year":"1996","journal-title":"Am Heart J"},{"key":"10.1016\/j.amepre.2005.08.042_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0735-1097(02)02670-0","article-title":"The underutilization of cardiac medications of proven benefit, 1990 to 2002","volume":"41","author":"Stafford","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amepre.2005.08.042_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amepre.2004.03.008","article-title":"Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System","volume":"27","author":"Kim","year":"2004","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.amepre.2005.08.042_bib21","first-page":"1","article-title":"Public health surveillance for behavioral risk factors in a changing environment. Recommendations from the Behavioral Risk Factor Surveillance Team","volume":"52","author":"Mokdad","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.amepre.2005.08.042_bib22","first-page":"366","article-title":"Design, characteristics, and usefulness of state-based behavioral risk factor surveillance","volume":"103","author":"Remington","year":"1988","journal-title":"Public Health Rep"},{"key":"10.1016\/j.amepre.2005.08.042_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/01621459.1978.10479995","article-title":"Sampling methods for random digit dialing","volume":"73","author":"Waksberg","year":"1978","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.amepre.2005.08.042_bib24","series-title":"BRFSS\u2014turning information into health","year":"2005"},{"key":"10.1016\/j.amepre.2005.08.042_bib25","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bmj.326.7404.1419","article-title":"A strategy to reduce cardiovascular disease by more than 80%","volume":"326","author":"Wald","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.amepre.2005.08.042_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001","volume":"289","author":"Mokdad","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amepre.2005.08.042_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.290.2.199","article-title":"Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988\u20132000","volume":"290","author":"Hajjar","year":"2003","journal-title":"JAMA"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379705003478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379705003478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T04:58:31Z","timestamp":1586667511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379705003478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0749379705003478"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2005.08.042","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}